Objective To further explore whether the management of chronic kidney disease (CKD) before dialysis has a long-term effect in the period after hemodialysis, so as to contribute to the better promotion of CKD management from the perspective of economics and demography. Methods This study enrolled 70 patients with initial hemodialysis from the CKD Outpatient Clinic (management group, group M) and 142 patients with initial hemodialysis from the Nephrology Clinic (non-management group, group NM) in the Affiliated Hospital of Jiangsu University in the period from March 2015 to March 2018. The patients were followed up for 5 years, and the hospitalization and expenses at the initial of dialysis and within 1 year after dialysis, as well as the death at 1 year and 5 years after dialysis were compared between the two groups, and the influence of various factors on all-cause death was analyzed. Results When starting dialysis, the total hospitalization cost per capita in group NM was significantly higher than that in the group M (t=-3.100，P=0.002). The total hospitalization cost per capita in group M was significantly lower than that in the group NM within 1 year after dialysis (t=-2.269, P=0.024), this is mainly due to a decrease in the cost of medicines, tests, treatments, surgeries and blood transfusions. Multiple linear regression found that CKD management was independently associated with a reduction in total inpatient costs per patient, whether unadjusted, adjusted for age and sex, adjusted for comorbidities, adjusted for baseline laboratory measures at hemodialysis starting, or adjusted for vascular access at hemodialysis initiation, at the time of initiation of dialysis and within one year after initiation of dialysis (Dialysis start-up β=0.386, 0.392, 0.392, 0.359, 0.248，P＜0.001, ＜0.001, ＜0.001, ＜0.001, =0.018, respectively; Within 1 year of dialysis β=0.151, 0.154, 0.148, 0.168, 0.343，P=0.028, 0.025, 0.038, 0.021, 0.002, respectively). Kaplan-Meier analysis showed that the 5-year cumulative survival rate difference was statistically significant (χ2=3.947, P=0.047). The results of multivariate analysis showed that age and diabetes mellitus were independent risk factors for all-cause death (HR=1.042, 0.390,95% CI: 1.021～1.062, 0.226～0.671, P＜0.001, 0.001), while pre-dialysis CKD management was protective factor for all-cause death (HR=0.503, 95% CI: 0.295～0.857, P=0.012). Conclusions Pre-dialysis CKD management has a legacy effect on post-dialysis economic outcomes and can improve the long-term prognosis of maintenance hemodialysis patients, we should pay more attention to diabetes and elderly patients in CKD management.
YU Shu
,
JIA Jue
,
WANG Tao-Tao
,
XU Feng-Lan
,
GUI Lan-Lan
,
HUA Qin
,
HE Jian-Qiang
. Effects of pre-dialysis chronic kidney disease management on hospitalization costs in one year and long-term mortality in maintenance hemodialysis patients[J]. Chinese Journal of Blood Purification, 2024
, 23(09)
: 646
-650
.
DOI: 10.3969/j.issn.1671-4091.2024.09.002
[1]World Health 0rganization.World Health Statistics 2020[R].Geneva:World Health 0rganization, 2020．
[2]Versino E, Piccoli G.Chronic kidney disease:the complex history of the organization of Long-Term care and bioethicswhy now，more than ever，action is needed[J].International journal of Environmental Research and Public Health, 2019, 16(5):785-
[3]Zhang H, Zhang C, Zhu S, et a.Direct medical costs of end-stage kidney disease and renal replacement therapy：a cohort study in Guangzhou City，southern China[J].BMC Health services Research, 2020, 20(1):122-
[4]Wu IW, Wang SY, Hsu KH, et al.Multidisciplinary predialysis education decreases the incidence of dialysis and reduces mortality-a controlled cohort study based on the NKFDOQI guidelines[J].Nephrol Dial Transplant, 2009, 24(11):3426-3433
[5]余 姝，贾 珏，, 王涛涛，等.慢性肾脏病管理对糖尿病肾病进展及透析启动的影响[J].中国血液净化, 2023, 22(6):415-419
[6]余姝, 华琴, 朱文芳, 等.透析前慢性肾脏病门诊管理对维持性血液透析患者的益处[J].中国血液净化, 2018, 17(8):529-533
[7]Wei SY, Chang YY, Mau LW, et al.Chronic kidney disease care program improves quality of pre-end-stage renal disease care and reduces medical costs[J].Nephrology, 2010, 15(1):108-115
[8] Yu S, Jiachuan X, Yan C, et al.The effectiveness of multidisciplinary care models for patients with chronic kidney disease: a systematic review and meta-analysis[J]. [J].Int Urol Nephrol, 2018, 50(2):301-312
[9]Chen PM, Lai TS, Chen PY, et al.Multidisciplinary care program for advanced chronic kidney disease: reduces renal replacement and medical costs[J].Am J Med, 2015, 128(1):68-76
[10]Stroupe KT, Fischer MJ, Kaufman JS, et al.Predialysis nephrology care and costs in elderly patients initiating dialysis[J].Med Care, 2011, 49(3):248-256
[11]Chen SH, Tsai YF, Sun CY, et al.The impact of self-management support on the progression of chronic kidney disease-a prospective randomized controlled trial[J].Nephrol Dial Transplant, 2011, 26(11):3560-3566
[12]Nakai S, Iseki K, Itami N，et al.An overview of regular dialysis treatment in Japan(as of 31 December 2010)[J].Ther Apher Dial, 2012, 14(6):483-521
[13] Sun Y, Wang Y, Yu W, et al.Association of dose and frequency on the survival of patients on maintenance of hemodialysis in China:A Kaplan- Meier and Cox- proportional hazard model analysis[J][J].Med Sci Monit, 2018, 24:5329-5337
[14].
[15]Kurella Tamura M, Li S, Chen S C, et al.Educational programs improve the preparation for dialysis and survival of patients with chronic kidney disease[J].Kidney International, 2014, 85(3):686-692
[16]Nee R, Fisher E, Yuan C M, et al.Pre-End-Stage Renal Disease Care and Early Survival among Incident Dialysis Patients in the US Military Health System[J].American Journal of Nephrology, 2017, 45(6):464-472
[17]Lin Ming-Yen, Cheng Li-Jen, Chiu Yi-Wen, et al.Effect of national pre-ESRD care program on expenditures and mortality in incident dialysis patients: A population -based study[J].PLoS One, 2018, 13(6):e0198387-
[18]Tsur N, Menashe I, Haviv YS.Risk factors before Dialysis Predominate as Mortality Predictors in Diabetic Maintenance Dialysis patients[J].Sci Rep, 2019, 9(1):10633-
[19]汤颖，钟一红，龚邵敏，等.终末期肾病血液透析患者感染死亡事件调查[J].中华肾脏病杂志, 2011, 27(6):406-410
[20]Myers O B, Adams C, Rohrscheib M R, et al.Age,Race,Diabetes,Blood Pressure,and Mortality among Hemodialysis Patients[J].Journal of the American Society of Nephrology, 2010, 21(11):1970-1978
[21]DE JAGER D J, HALBESMA N, KREDIET R T, et al.Is the decline of renal function different before and after the start of dialysis?[ J ][J].Nephrol Dial Trans-plant, 2013, 28(3):698-705
[22]LIM W H, JOHNSON D w, HAWLEY c, et al.Type 2 diabetes in patients with end-stage kidney disease: influence on cardiovascular disease related mortality risk[J].Med J Aust, 2018, 209(10):440-446
[23].Erratum Regarding " US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States" [J].Am J Kidney Dis, 2015, 66(3):545-
[24] El-Atat FA, Stas SN, McFarlane SI, et al.The relationship between hyperinsulinemia, hypertension and progressive renal disease[J].[J].J Am Soc Nephrol, 2004, 15(11):2816-2827
[25]CHANG Y T, WU J L, HSU C C, et al.Diabetes and end-stage renal disease synergistically contribute to increased incidence of cardiovascular events:a nationwide follow-up study during 1998-2009[J].Diabetes Care, 2014, 37(1):277-285
[26]KRAMER A, STEL V S, ABAD DIEZ J M, et al.Renal replacement therapy in Europe-a sum ary of the 2010 ERAEDTA Registry[J].ReportClin Kidney, 2013, 6(1):105-
[27]OLIVA J S, ROA L M, LARA A, et al.Survival and factors predicting mortality in hemodialysis patients over 75 years old[J].J Nephrol, 2013, 26(1):129-135
[28] Sladoje-Martinovic B, Mikolasevic I, Bubic I, et al.Survival of chronic hemodialysis patients over 80 years of age[J].[J].Clin Interv Aging, 2014, 9:689-696
[29]SHROFF R C, MCNAIR R J, SKEPPER J N, et al.Chronic mineral dysregulation promotes vascular smooth muscle cell adaptation and extracellular matrix calcification[J].J Am Soc Nephrol, 2010, 21(1):103-112
